SAN.PA Sanofi
Company Analysis
Latest News
Sanofi Taps Roche Veteran Paulo Fontoura to Lead Global R&D Transformation
Sanofi appointed Paulo Fontoura as Executive Vice President and Global Head of Research & Development Pharma. The appointment becomes effective September 1,...
Sanofi Wins EU Approval for Cenrifki, First to Target MS Disability
The European Commission approved Sanofi's drug Cenrifki (tolebrutinib) for adults with secondary progressive multiple sclerosis (SPMS) without recent relapses....
Sanofi Wins Japan Approval for Sarclisa Injection, Reducing Patient Treatment Burden
Sanofi received approval from Japan’s Ministry of Health, Labour and Welfare for the subcutaneous formulation of Sarclisa. This isatuximab injection treats...
Sanofi wins FDA approval for Tzield, first Stage 3 pediatric diabetes drug
Sanofi received FDA accelerated approval for Tzield (teplizumab-mzwv). The treatment targets children aged eight to 17 recently diagnosed with stage 3 type 1...
Sanofi Halts Phase 3 Riliprubart Trial, Citing Lack of Efficacy
Sanofi terminated its Phase 3 MOBILIZE clinical trial for riliprubart, an investigational antibody targeting chronic inflammatory demyelinating polyneuropathy...